Suboptimal Etravirine Activity is Common During Failure of Nevirapine-Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1

Babafemi Taiwo, Phyllis J. Kanki(Harvard University), Robert L. Murphy(Center for Global Health), Seema Meloni(Harvard University), Isaac F. Adewole(University of Ibadan), Beth Chaplin(Harvard University Press), Sudhir Penugonda(ClearMotion (United States)), Wadzani Gashau(University of Maiduguri), John Idoko(University of Jos), Sulaimon Akanmu(University of Lagos)
Current HIV Research
April 1, 2010
10.2174/157016210791111098
Cited by 18

Related Papers

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
Persistent HIV-1 replication maintains the tissue reservoir during therapy
|Nature|2016|632
Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study
|PLoS Medicine|2009|420
The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation
|AIDS|2014|385
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
|AIDS|2001|255